The facility is expected to produce 500 million vaccine doses annually
Kenya has signed a deal with US biotechnology company, Moderna Inc, to build a vaccine manufacturing facility in the country.
The facility if expected to produce up to 500 million doses of vaccines annually.
The deal has been hailed as one that will help solve vaccine access in the current coronavirus pandemic and in future pandemics.
Moderna anticipates to invest more than $500m (£380m) in the facility.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Today’s front pages: Tuesday, November 5, 2024
9 mins -
Galamsey: Investigation into attack on Joy News’ Erastus Asare and colleagues already growing cold
41 mins -
Mahama promises construction of stadia in all 16 regions if elected
58 mins -
Dampare has transformed Police training school – Bawumia
1 hour -
America braced as two stark visions collide on election day
1 hour -
NAPO urges Ghanaians to support NPP’s vision for national development
1 hour -
About 95% of PWDs in Obuasi have source of livelihood – MCE
1 hour -
Immigration Service intercepts 54 gallons of fuel
1 hour -
Election 2024: Roman Fada selected as flagbearer for Ghana Freedom Party
2 hours -
Bawumia to launch Ghana’s credit scoring system on Nov. 7
2 hours -
Alan to combat galamsey with strategic youth-centred business model
2 hours -
Agona Swedru chiefs commit to ending child marriage within their jurisdiction
2 hours -
Sunyani Traditional Council endorses Bawumia – NAPO government
2 hours -
Adutwum defends double track in Free SHS, citing research and positive outcomes
2 hours -
‘Prevent and condemn illegal pressure on Judiciary’ – AG to GBA
2 hours